|
Market Closed -
Nasdaq
16:30:00 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 0.6574 USD | -3.32% |
|
-7.66% | -42.33% |
| 10-26 | Top Premarket Gainers | MT |
| 10-12 | Iridex Says Glaucoma Therapy Lowers Eye Pressure, Reduces Medication Use | MT |
Evolution of the Average Target: IRIDEX Corporation
Evolution of the Target Price: IRIDEX Corporation
Changes in Analyst Recommendations: IRIDEX Corporation
cbed4acd1a0fa9.bQ39Oag3quxznBp2BJRuI7WSGIzJQA-f9oyU9N4Hhps.CG_McOlC77MgpXFEafNad_ihYdzwE2f9hPnuwu5x39cIRJ4N2WPrjyrpWw~593d90f79920a315ea3eeecb8d8ce76f
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +318.31% | |||
| +8.26% | |||||
| +12.88% | |||||
| +6.6% | |||||
| +16.02% | |||||
| +3.87% | |||||
| +1.65% | |||||
| +4.17% | |||||
| -0.07% | |||||
| +3.74% | |||||
| Average | +37.54% | |||||
| Weighted average by Cap. | +7.74% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6574USD
Average target price
2.750USD
Spread / Average Target
+318.31%
High Price Target
2.750USD
Spread / Highest target
+318.31%
Low Price Target
2.750USD
Spread / Lowest Target
+318.31%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- IRIX Stock
- Consensus IRIDEX Corporation
Select your edition
All financial news and data tailored to specific country editions
